Sign in

CIK 0000715446

  • Non-accelerated filer
  • Smaller reporting company

Anixa Biosciences Inc

Sign in to watch
Ticker
ANIX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Oct 31
Incorporated
DE
Entity type
Operating
EIN
112622630
Phone
+1 408-708-9808
Business address
3150 ALMADEN EXPRESSWAY, SUITE 250, SAN JOSE, CA, 95118
Former names
ITUS Corp, COPYTELE INC
Open-market buys, last 90 days
$291,587
in 10 filings
Open-market sales, last 90 days
$0
in 0 filings

Net +$291,587. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-01-05 Gottschalk Emily Director Grant or award · Employee Stock Option +25,000 25,000
2025-01-02 Gottschalk Emily Director Grant or award · Employee Stock Option +25,000 25,000
2024-01-12 Gottschalk Emily Director Grant or award · Employee Stock Option (Right to Buy) +25,000 25,000
2023-01-03 Gottschalk Emily Director Grant or award · Employee Stock Option (Right to Buy) +25,000 25,000
2022-03-10 Gottschalk Emily Director Grant or award · Employee Stock Option (Right to Buy) +100,000 100,000
2021-07-15 Gottschalk Emily Director Purchase +20,065 $3.96 $79K 45,665
2021-06-01 Gottschalk Emily Director Grant or award · Employee Stock Option (Right to Buy) +30,000 30,000
2021-04-23 Gottschalk Emily Director Purchase +10,000 $4.49 $45K 25,600
2021-03-25 Gottschalk Emily Director Purchase +15,600 $4.88 $76K 15,600
2020-08-13 Gottschalk Emily Director Grant or award · Employee Stock Option (Right to Buy) +30,000 30,000
2019-10-23 Gottschalk Emily Director Grant or award · Employee Stock Option (Right to Buy) +45,000 45,000

Page 1 of 1 · 11 trades